Stiefel

Stockley Park West, , Uxbridge, Middlesex, UB11 1BT , UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com


Summary of Product Characteristics last updated on the eMC: 21/10/2011
SPC PanOxyl 2.5 Aquagel 2.5%w/w Gel


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

PanOxyl 2.5 Aquagel 2.5%w/w Gel

PanOxyl Aquagel 2.5


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Benzoyl peroxide 2.5% w/w

Also contains propylene glycol. For a full list of excipients, see section 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Gel


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

The product is indicated for use in the topical treatment of acne vulgaris.


Go to top of the page
4.2 Posology and method of administration

Treatment should normally begin with PanOxyl Aquagel 2.5. Apply to the affected areas once daily. Washing prior to application enhances the efficacy of the preparation.

The reaction of the skin to benzoyl peroxide differs in individual patients. The higher concentration in PanOxyl Aquagel 5 or 10 may be required to produce a satisfactory response.


Go to top of the page
4.3 Contraindications

PanOxyl Aquagel should not be prescribed for patients with a known hypersensitivity to benzoyl peroxide.


Go to top of the page
4.4 Special warnings and precautions for use

Avoid contact with the eyes, mouth and mucous membranes. Care should be taken when applying the product to the neck and other sensitive areas.

During the first few days of treatment a moderate reddening and peeling will occur. During the first few weeks of treatment a sudden increase in peeling will occur in most patients. This is not harmful and will normally subside within a day or two if treatment is discontinued. If excessive irritation, redness or peeling occurs, discontinue use.

The product may bleach dyed fabrics.

PanOxyl 2.5 Aquagel contains propylene glycol. Propylene glycol may cause skin irritation.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None


Go to top of the page
4.6 Pregnancy and lactation

There are no restriction on the use of PanOxyl Aquagel in pregnancy and lactation.


Go to top of the page
4.7 Effects on ability to drive and use machines

None


Go to top of the page
4.8 Undesirable effects

None


Go to top of the page
4.9 Overdose

Not applicable.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Benzoyl peroxide has sebostatic and keratolytic activity coupled with antibacterial activity against Propionibacterium acnes, the organism implicated in acne vulgaris. Its use in the treatment of acne is well established.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable.


Go to top of the page
5.3 Preclinical safety data

Not applicable. Benzoyl peroxide has been in widespread use for many years.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Carbomer 940

Di-isopropanolamine

Propylene glycol

Polyoxyethylene lauryl ether

Sodium lauryl sulphate

Purified water


Go to top of the page
6.2 Incompatibilities

None


Go to top of the page
6.3 Shelf life

12 months


Go to top of the page
6.4 Special precautions for storage

Store below 25°C.


Go to top of the page
6.5 Nature and contents of container

Internally lacquered aluminium tubes with screw caps. Licensed pack sizes: 40g and 50g.


Go to top of the page
6.6 Special precautions for disposal and other handling

There are no special instructions for use or handling of PanOxyl 2.5.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

GlaxoSmithKline UK Limited

980 Great West Road

Brentford

Middlesex

TW8 9GS

Trading as Stiefel

Stockley Park West

Uxbridge

Middlesex

UB11 1BT


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 19494/0057


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

21st August 1984


Go to top of the page
10. DATE OF REVISION OF THE TEXT

18 October 2011



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/2120/SPC/


Active Ingredients/Generics

 
   benzoyl peroxide